• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于甲基化驱动的基因预后特征和上皮性卵巢癌的免疫微环境。

A methylation-driven genes prognostic signature and the immune microenvironment in epithelial ovarian cancer.

机构信息

Department of Gynecology, Cancer Hospital of China Medical University, Dadong District, Shenyang, Liaoning Province, People's Republic of China.

Department of Gynecology, Liaoning Cancer Hospital & Institute, Dadong District, Shenyang, Liaoning Province, People's Republic of China.

出版信息

Carcinogenesis. 2022 Aug 30;43(7):635-646. doi: 10.1093/carcin/bgac048.

DOI:10.1093/carcin/bgac048
PMID:35639961
Abstract

Aberrant gene methylation has been implicated in the development and progression of tumors. In this study, we aimed to identity methylation-driven genes involved in epithelial ovarian cancer (EOC) to establish a prognostic signature for patients with EOC. We identified and verified 6 MDGs that are closely related to the prognosis of ovarian cancer. A prognostic risk score model and nomogram for predicting the prognosis of ovarian cancer were constructed based on the six MDGs. It can also effectively reflect the immune environment and immunotherapy response of ovarian cancer. These MDGs have great significance to the implementation of individualized treatment and disease monitoring of ovarian cancer patients.

摘要

异常基因甲基化与肿瘤的发生和发展有关。在这项研究中,我们旨在确定参与卵巢上皮性癌(EOC)的甲基化驱动基因,为 EOC 患者建立预后标志物。我们鉴定并验证了 6 个与卵巢癌预后密切相关的 MDGs。基于这 6 个 MDGs,构建了预测卵巢癌预后的风险评分模型和列线图。它还可以有效地反映卵巢癌的免疫环境和免疫治疗反应。这些 MDGs 对实施卵巢癌患者的个体化治疗和疾病监测具有重要意义。

相似文献

1
A methylation-driven genes prognostic signature and the immune microenvironment in epithelial ovarian cancer.基于甲基化驱动的基因预后特征和上皮性卵巢癌的免疫微环境。
Carcinogenesis. 2022 Aug 30;43(7):635-646. doi: 10.1093/carcin/bgac048.
2
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.基于免疫相关长非编码 RNA 的上皮性卵巢癌预后模型。
J Ovarian Res. 2022 Jan 15;15(1):8. doi: 10.1186/s13048-021-00930-w.
3
Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma.乙酰化模型预测上皮性卵巢癌患者的预后,并影响免疫微环境浸润。
J Ovarian Res. 2024 Jul 19;17(1):150. doi: 10.1186/s13048-024-01449-6.
4
Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.基于 TCGA 数据库的上皮性卵巢癌肿瘤突变负荷的多组学分析与预后评估。
Int J Med Sci. 2020 Oct 23;17(18):3200-3213. doi: 10.7150/ijms.50491. eCollection 2020.
5
Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration.基于肿瘤免疫微环境探索的卵巢上皮癌预后标志物的鉴定。
Genomics. 2020 Nov;112(6):4827-4841. doi: 10.1016/j.ygeno.2020.08.027. Epub 2020 Sep 2.
6
Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer.卵巢癌中与细胞坏死相关的基因特征的鉴定和验证及其对预后和肿瘤免疫微环境的影响。
Front Immunol. 2022 Jun 24;13:894718. doi: 10.3389/fimmu.2022.894718. eCollection 2022.
7
Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis.上皮性卵巢癌干细胞分化的表观基因组分析揭示了 GPD1 相关的免疫抑制微环境和不良预后。
Int J Mol Sci. 2022 May 4;23(9):5120. doi: 10.3390/ijms23095120.
8
The Comprehensive Analysis of Interferon-Related Prognostic Signature with regard to Immune Features in Ovarian Cancer.卵巢癌中干扰素相关预后特征与免疫特征的综合分析。
Dis Markers. 2022 Jun 20;2022:7900785. doi: 10.1155/2022/7900785. eCollection 2022.
9
CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients.CAMK2N1/RUNX3 甲基化是铂类敏感型上皮性卵巢癌患者无进展生存期和总生存期的独立预后生物标志物。
Clin Epigenetics. 2021 Jan 22;13(1):15. doi: 10.1186/s13148-021-01006-8.
10
Systematic Construction and Validation of an Immune-Related Gene-Based Model to Predict Prognosis for Ovarian Cancer.基于免疫相关基因的系统构建和验证模型预测卵巢癌预后。
Biomed Res Int. 2022 Apr 21;2022:7356992. doi: 10.1155/2022/7356992. eCollection 2022.

引用本文的文献

1
Identifying a Risk Signature of Methylation-Driven Genes as a Predictor of Survival Outcome for Colon Cancer Patients.鉴定甲基化驱动基因的风险特征作为结直肠癌患者生存结局的预测因子。
Appl Biochem Biotechnol. 2024 Jul;196(7):4156-4165. doi: 10.1007/s12010-023-04751-z. Epub 2023 Oct 31.